Entrada Therapeutics, Inc. Share-based Payment Arrangement, Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-05
- Entrada Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $5.15M, a 2.02% increase year-over-year.
- Entrada Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $4.74M, a 6.74% decline year-over-year.
- Entrada Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $4.36M, a 7.28% decline year-over-year.
- Entrada Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $5.12M, a 5.27% increase year-over-year.
- Entrada Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2025 was $19.61M, a 9.46% increase from fiscal 2024.
- Entrada Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2024 was $17.91M, a 36.64% increase from fiscal 2023.
- Entrada Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $13.11M, a 32.50% increase from fiscal 2022.
- Entrada Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $9.89M, a 291.73% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.15M 10-Q · filed 2026-08-05 | $9.89M 10-Q · filed 2026-08-05 | $14.25M derived: sum of 3 quarters · filed 2026-08-05 | $19.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $4.74M 10-Q · filed 2026-05-07 | $9.10M derived: sum of 2 quarters · filed 2026-05-07 | $14.22M derived: sum of 3 quarters · filed 2026-05-07 | $19.27M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.47M derived: sum of 2 quarters · filed 2026-02-26 | $14.52M derived: sum of 3 quarters · filed 2026-08-05 | $19.61M 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.12M 10-Q · filed 2025-11-06 | $10.16M derived: sum of 2 quarters · filed 2026-08-05 | $15.25M 10-Q · filed 2025-11-06 | $19.95M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $5.05M 10-Q · filed 2026-08-05 | $10.13M 10-Q · filed 2026-08-05 | $14.84M derived: sum of 3 quarters · filed 2026-08-05 | $19.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.09M 10-Q · filed 2026-05-07 | $9.79M derived: sum of 2 quarters · filed 2026-05-07 | $14.65M derived: sum of 3 quarters · filed 2026-05-07 | $19.27M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.56M derived: sum of 2 quarters · filed 2026-02-26 | $14.18M derived: sum of 3 quarters · filed 2026-02-26 | $17.91M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.86M 10-Q · filed 2025-11-06 | $9.48M derived: sum of 2 quarters · filed 2025-11-06 | $13.21M 10-Q · filed 2025-11-06 | $17.06M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $4.62M 10-Q · filed 2025-08-06 | $8.36M 10-Q · filed 2025-08-06 | $12.20M derived: sum of 3 quarters · filed 2025-08-06 | $15.59M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $3.73M 10-Q · filed 2025-05-08 | $7.57M derived: sum of 2 quarters · filed 2025-05-08 | $10.97M derived: sum of 3 quarters · filed 2025-05-08 | $14.09M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $7.24M derived: sum of 2 quarters · filed 2025-02-27 | $10.36M derived: sum of 3 quarters · filed 2025-02-27 | $13.11M 10-K · filed 2025-02-27 |
| 2023-09-30 | $3.40M 10-Q · filed 2024-11-05 | $6.51M derived: sum of 2 quarters · filed 2024-11-05 | $9.27M 10-Q · filed 2024-11-05 | $12.15M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $3.12M 10-Q · filed 2024-08-13 | $5.87M 10-Q · filed 2024-08-13 | $8.76M derived: sum of 3 quarters · filed 2024-08-13 | $11.46M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.75M 10-Q · filed 2024-05-07 | $5.64M derived: sum of 2 quarters · filed 2024-05-07 | $8.34M derived: sum of 3 quarters · filed 2024-05-07 | $10.86M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $5.59M derived: sum of 2 quarters · filed 2024-03-13 | $8.10M derived: sum of 3 quarters · filed 2024-03-13 | $9.89M 10-K · filed 2024-03-13 |
| 2022-09-30 | $2.71M 10-Q · filed 2023-11-07 | $5.22M derived: sum of 2 quarters · filed 2023-11-07 | $7.01M 10-Q · filed 2023-11-07 | $8.47M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.51M 10-Q · filed 2023-08-08 | $4.31M 10-Q · filed 2023-08-08 | $5.76M derived: sum of 3 quarters · filed 2023-08-08 | $6.34M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.79M 10-Q · filed 2023-05-10 | $3.25M derived: sum of 2 quarters · filed 2023-05-10 | $3.83M derived: sum of 3 quarters · filed 2023-05-10 | $4.16M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $2.04M derived: sum of 2 quarters · filed 2023-03-06 | $2.36M derived: sum of 3 quarters · filed 2023-03-06 | $2.53M 10-K · filed 2023-03-06 |
| 2021-09-30 | $578.00K 10-Q · filed 2022-11-07 | $904.00K derived: sum of 2 quarters · filed 2022-11-07 | $1.07M 10-Q · filed 2022-11-07 | $1.17M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $326.00K 10-Q · filed 2022-08-11 | $490.00K 10-Q · filed 2022-08-11 | $588.00K derived: sum of 3 quarters · filed 2022-08-11 | $663.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $164.00K 10-Q · filed 2022-05-12 | $262.00K derived: sum of 2 quarters · filed 2022-05-12 | $337.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $173.00K derived: sum of 2 quarters · filed 2022-03-15 | $325.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $75.00K 10-Q · filed 2021-12-09 | $227.00K 10-Q · filed 2021-12-09 |